Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000295045

Medchemexpress LLC Rp-1664 | 2980682-00-4 | 98.8% | 514.55 g/mol | C23H24F2N8O2S | 10 MG
SDP

Catalog No. 5000295045
Encompass_Preferred

RP-1664 is a selective, orally active inhibitor of Polo-like kinase 4 (PLK4) used in preclinical oncology and cell-biology research. It potently inhibits PLK4 (IC50 = 3 nM), disrupts centriole biogenesis, and induces centrosome loss in cellular models.

  • Selective PLK4 inhibition (IC50 = 3 nM).
  • Disrupts centriole biogenesis and induces centrosome loss.
  • High purity (98.8%).
  • Molecular weight 514.55 g/mol; formula C23H24F2N8O2S.
  • DMSO solubility 100 mg/mL (ultrasonic recommended).
  • Powder storage -20°C (3 years); in solvent -80°C (6 months).

Catalog No. 50-002-95045 Supplier Medchemexpress LLC Supplier No. HY17273710MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

RP-1664 is a selective, orally active inhibitor of Polo-like kinase 4 (PLK4) used in preclinical oncology and cell-biology research. It potently inhibits PLK4 (IC50 = 3 nM), disrupts centriole biogenesis, and induces centrosome loss in cellular models.

  • Selective PLK4 inhibition (IC50 = 3 nM).
  • Disrupts centriole biogenesis and induces centrosome loss.
  • High purity (98.8%).
  • Molecular weight 514.55 g/mol; formula C23H24F2N8O2S.
  • DMSO solubility 100 mg/mL (ultrasonic recommended).
  • Powder storage -20°C (3 years); in solvent -80°C (6 months).

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.